SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased social and trading activity driven by news of its quantum-resistant technology being cited by Google researchers, alongside anticipation for US regulatory clarity. The community remains divided between long-term holders optimistic about its institutional utility and active traders debating the impact of ongoing market volatility.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly's recent FDA approval for the oral weight-loss drug Foundayo has intensified competition with Novo Nordisk, triggering active community debate over drug efficacy, side-effect profiles, and the convenience of daily pill formats versus injectables. Investors and enthusiasts are closely watching how this approval impacts long-term market share as the obesity drug sector enters a new phase of oral treatment proliferation.

Verizon Communications, Inc. is a holding company, which engages in the provision of communications, information, and entertainment products and services. It operates through the Consumer and Business segments. The Consumer segment provides consumer-focused wireless and wire line communications services and products. The Business segment offers wireless and wireline communications services and products, including FWA broadband, data, video and conferencing services, corporate networking solutions, security and managed network services, local and long-distance voice services, and network access to deliver various IoT services and products. The company was founded in 1983 and is headquartered in New York, NY.

Verizon Communications Inc

Verizon Communications Inc.

Verizon is trending as investors closely watch upcoming earnings and scrutinize the new leadership's ability to manage high debt levels while balancing subscriber growth against competitive market pressures. The community remains divided, with some betting on a defensive dividend play and share buybacks, while others express frustration over persistent service quality issues and skepticism toward the company's long-term growth narrative.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to heightened speculation surrounding a potential buyout or major partnership, as investors track ongoing M&A activity in the weight-loss drug sector and analyze the competitive potential of VK2735 against industry leaders. The community is actively discussing the company's clinical trial progress and the perceived undervaluation of its obesity pipeline, with many members dismissing recent share price volatility as market noise in anticipation of upcoming data readouts.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is trading in a volatile, highly speculative range as investors wait for a pivotal Type A meeting with the FDA regarding a Complete Response Letter (CRL) for its lead melanoma candidate, RP1. The community is sharply divided, with bulls pointing to strong clinical trial data and oncology expert support as catalysts for a potential regulatory reset, while bears cite the company's precarious cash runway, the uncertainty of a new trial design, and the historical difficulty of reversing FDA decisions.

KLA Corp. engages in the supply of process control and yield management solutions for the semiconductor and related nano-electronics industries. The company operates through the following segments: Semiconductor Process Control, Specialty Semiconductor Process, and PCB, Display and Component Inspection. The Semiconductor Process Control segment provides a comprehensive portfolio of inspection, metrology and data analytics products and related services. The Specialty Semiconductor Process segment develops and sells advanced vacuum deposition and etching process tools. The PCB, Display and Component Inspection segment enables electronic device manufacturers to inspect, test and measure PCBs, flat panel displays and ICs to verify their quality. Its products include manufactured chips, reticle, packaging, surface profilers, nanochemical testers, KT pro equipment, and compound semiconductors. The company was founded on July 9, 1975 and is headquartered in Milpitas, CA.

KLA Corp.

KLA Corp. is currently trending as investors weigh strong capital return initiatives, including aggressive share buybacks, against ongoing concerns regarding semiconductor sector volatility and geopolitical supply chain risks. The community remains closely divided between the bull case, centered on KLA's essential role in advanced process control for the AI roadmap, and the bear case, driven by macro uncertainty and equipment delivery headwinds.

Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. It operates through the following segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a broad range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. The Specialties segment focuses on optimizing a portfolio of bromine and specialized lithium solutions. The Ketjen segment consists of clean fuels technologies, fluidized catalytic cracking catalysts and additives, and performance catalyst solutions, which is primarily composed of organometallics and curatives. The company was founded in 1993 and is headquartered in Charlotte, NC.

Albemarle Corp.

Albemarle Corp

Albemarle is surging as investor sentiment shifts toward a potential lithium market recovery, with the community closely tracking positive analyst upgrades and strategic supply chain developments. The primary talking point centers on the critical role of lithium in energy storage and data center infrastructure, fueling a bullish outlook on long-term supply constraints despite ongoing sector volatility.

The Render Network is a leading decentralized GPU compute platform for applications ranging from 3D rendering to machine learning and generative AI.  The network connects node operators looking to monetize their idle GPU compute power with artists and developers looking to scale intensive 3D rendering work and machine learning applications in the cloud. Through a decentralized peer-to-peer network, the Render Network achieves unprecedented levels of scale, speed, and economic efficiency. Facilitated by the Render Network Foundation, the ecosystem empowers artists and developers to build services and applications for the emerging digital economy.

Render Token (SOL)

Render Token is capturing significant community attention as investors debate its role in the decentralized AI compute sector and potential for long-term growth. The community remains polarized, with many retail participants actively accumulating to lower their cost basis while others debate the impact of exchange delistings and overall market volatility.

Olin Corp. engages in the manufacturing of chemicals products. It operates through the following segments: Chlor Alkali Products and Vinyls, Epoxy, and Winchester. The Chlor Alkali Products and Vinyls segment manufactures and sells chlorine and caustic soda, ethylene dichloride and vinyl chloride monomer, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, trichloroethylene and vinylidene chloride, hydrochloric acid, hydrogen, bleach products and potassium hydroxide. The Epoxy segment produces and sells epoxy materials, which include allyl chloride, epichlorohydrin, liquid epoxy resins and downstream products such as converted epoxy resins and additives. The Winchester segment creates and sells sporting ammunition, reloading components, small caliber military ammunition and components, and industrial cartridges. The company was founded by Franklin W. Olin on August 13, 1892 and is headquartered in Clayton, MO.

Olin Corp.

Olin Corporation is trending as investors weigh its role as an essential supplier for the defense and critical minerals sectors against broader macroeconomic headwinds. The community is actively discussing the company's potential as a 'picks and shovels' play for the energy transition and military ammunition needs, with significant options activity fueling speculation about upcoming corporate events.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is currently trending as traders aggressively monitor its price action against broader market volatility, with the community actively debating whether it serves as a resilient safe-haven asset or a high-risk derivative play. Discussions are primarily focused on the potential impact of token unlocks, its role in decentralized perpetual trading, and the competitive landscape of institutional-grade DeFi gateways.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETF Opportunities Trust - T-REX 2X Long CRWV Daily Target ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$4.97
Prev Close	$4.54
Open	$4.18
Dividend Yield	N/A
50-Day Moving Average	$6.37
Beta	N/A
Avg. Volume	1.75M
PE Ratio	N/A

52-Week High	$35.96
52-Week Low	$3.35
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

CRWU
T-REX 2X Long CRWV Daily Target ETF

Feed

News

Sentiment

Fundamentals

Info

Latest CRWU News

CRWUT-REX 2X Long CRWV Daily Target ETF